Your browser doesn't support javascript.
loading
Impact of ABCC2 polymorphisms on high-dose methotrexate pharmacokinetics in patients with lymphoid malignancy.
Simon, N; Marsot, A; Villard, E; Choquet, S; Khe, H-X; Zahr, N; Lechat, P; Leblond, V; Hulot, J-S.
Affiliation
  • Simon N; Aix-Marseille université, Service de Pharmacologie Médicale et Clinique, AP-HM, Hôpital de la Timone, Marseille, France.
Pharmacogenomics J ; 13(6): 507-13, 2013 Dec.
Article in En | MEDLINE | ID: mdl-23069858
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Methotrexate / Polymorphism, Single Nucleotide / Multidrug Resistance-Associated Proteins / Lymphoma / Antimetabolites, Antineoplastic Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Pharmacogenomics J Journal subject: BIOLOGIA MOLECULAR / FARMACOLOGIA Year: 2013 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Methotrexate / Polymorphism, Single Nucleotide / Multidrug Resistance-Associated Proteins / Lymphoma / Antimetabolites, Antineoplastic Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Pharmacogenomics J Journal subject: BIOLOGIA MOLECULAR / FARMACOLOGIA Year: 2013 Document type: Article Affiliation country: